On Friday, Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) opened lower -7.62% from the last session, before settling in for the closing price of $2.10. Price fluctuations for MRVI have ranged from $2.07 to $11.56 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 42.54% over the last five years. Company’s average yearly earnings per share was noted -154.72% at the time writing. With a float of $116.77 million, this company’s outstanding shares have now reached $141.98 million.
The firm has a total of 570 workers. Let’s measure their productivity. In terms of profitability, gross margin is 39.14%, operating margin of -90.29%, and the pretax margin is -100.89%.
Maravai LifeSciences Holdings Inc (MRVI) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Maravai LifeSciences Holdings Inc is 18.71%, while institutional ownership is 85.71%. The most recent insider transaction that took place on Jan 31 ’25, was worth 125,750. In this transaction General Counsel of this company sold 25,000 shares at a rate of $5.03, taking the stock ownership to the 167,618 shares. Before that another transaction happened on Jan 31 ’25, when Company’s Officer proposed sale 25,000 for $5.03, making the entire transaction worth $125,750.
Maravai LifeSciences Holdings Inc (MRVI) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -154.72% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.93% during the next five years compared to -64.27% drop over the previous five years of trading.
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Trading Performance Indicators
Check out the current performance indicators for Maravai LifeSciences Holdings Inc (MRVI). In the past quarter, the stock posted a quick ratio of 6.65. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.03, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.19 in one year’s time.
Technical Analysis of Maravai LifeSciences Holdings Inc (MRVI)
Analysing the last 5-days average volume posted by the [Maravai LifeSciences Holdings Inc, MRVI], we can find that recorded value of 3.42 million was better than the volume posted last year of 3.3 million. As of the previous 9 days, the stock’s Stochastic %D was 16.87%. Additionally, its Average True Range was 0.22.
During the past 100 days, Maravai LifeSciences Holdings Inc’s (MRVI) raw stochastic average was set at 1.46%, which indicates a significant decrease from 7.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.36% in the past 14 days, which was lower than the 112.87% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.4357, while its 200-day Moving Average is $6.3337. Now, the first resistance to watch is $2.0583. This is followed by the second major resistance level at $2.1767. The third major resistance level sits at $2.2683. If the price goes on to break the first support level at $1.8483, it is likely to go to the next support level at $1.7567. Should the price break the second support level, the third support level stands at $1.6383.
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Key Stats
There are currently 254,336K shares outstanding in the company with a market cap of 493.41 million. Presently, the company’s annual sales total 259,190 K according to its annual income of -144,850 K. Last quarter, the company’s sales amounted to 56,410 K and its income totaled -26,150 K.
